Smith Robin L
SEC-identified person · CIK 1365035 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Matinas Biopharma Holdings, Inc. MTNB] | Director | filed 2025–2025 |
| GX Acquisition Corp. GXGXU | Director | filed 2021–2023 |
| Western Acquisition Ventures Corp. WAVS | Director | filed 2022–2022 |
| Sorrento Therapeutics, Inc. SRNEQ | Director | filed 2019–2021 |
| Servicesource International, INC. SREV | Director | filed 2020–2020 |
| Seelos Therapeutics, INC. SEEL | Director | filed 2019–2020 |
| Rockwell Medical, INC. rmti | Director | filed 2016–2019 |
| Strativation, INC. STVT.OB | Director | filed 2015–2019 |
| Prolung INC [None] | Director | filed 2017–2018 |
| Viridian Therapeutics, Inc.\DE VRDN | Director | filed 2014–2017 |
| Phase III Medical INC/DE PHSM | Director · See Remarks | filed 2006–2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.